Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), preference for dialysis treatments over kidney transplants due to lack of donors, and initiatives taken by leading players to introduce advanced products & services.

The report China Hemodialysis and Peritoneal Dialysis Market is projected to reach USD 7.4 billion by 2024 from USD 5.0 billion in 2019, at a CAGR of 8.5%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150472097

Market Segments:-
The China hemodialysis market is broadly categorized into two segments, namely, hemodialysis products and hemodialysis services market. The hemodialysis (HD) products market include machines (center-use & home-use machines) & consumables (dialyzers, access products, bloodlines, dialysates, and other consumables). The hemodialysis services (including in-center & home- hemodialysis services) segment is expected to account for the largest share of the China dialysis market. An increasing number of dialysis centers coupled with the growing prevalence of ESRD is the major factor driving the growth of the hemodialysis services market in China.

Recent Developments:-
• In 2018, Fresenius Medical Care acquired 70% shares of Guangzhou KangNiDaiSi Medical Investment Co., Ltd. company to expand its dialysis care network in China
• In 2017, Fresenius Medical Care opened an independent dialysis center in Quanzhou (China). This expansion is aimed to increase access to dialysis treatment in the country.
• In 2015, DaVita entered into a joint venture with Shunjing Renal Hospital (China) to establish DaVita (Shandong) Kidney Disease Hospital Co., Ltd. to increase its footprint in the China dialysis service market.

Key Players:-
The major players operating in the China hemodialysis and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US) and Shandong Weigao Group Medical Polymer Company Limited (China). Other players in this market include B. Braun Melsungen AG (Germany), Nikkiso Co. Ltd. (Japan), DaVita Healthcare Partners, Inc (US), Asahi Kasei Medical Co., Ltd (Japan), Bain Medical Equipment Co., Ltd. (China), Huaren Pharmaceutical (China), and Jiangsu Lengthen Life Science and Technology Co. Ltd (China)